Seems the CELLMID thread has vanished. Needs a dose of its own medicine
Peer review, ASX announced, for the hair restorer.
Works on eyelashes too.
US alone spends 150 million p.a. on eyelashes.
Blinking crazy I'd say.:)
Printable View
Seems the CELLMID thread has vanished. Needs a dose of its own medicine
Peer review, ASX announced, for the hair restorer.
Works on eyelashes too.
US alone spends 150 million p.a. on eyelashes.
Blinking crazy I'd say.:)
Not that I usually bother correcting loose usage of our language MBJ...however rather than using US it would probably be better saying "we"...:eek2: However my compliments to you and your wife for your enthusiastic pursuit of a full head of hair....or are they for the dog? With that kind of ground base support it sounds like an inhairently good investment.
US - United States??
The dog has sufficient hair for all of us if I can figure out how to make wigs.
Great marketing ploy "Hair of the Dog"
Sorry about the U.S. chaps, suppose I deserved a tongue " lashing" for that.
(Dont go there):)
Theres more to this than meets the eye.
The current market LEADER in drug treatments for eyelash, Latisse, sells over 150 million annually in the USA alone.
Most of that was for sales to Tammy Faye Baker
http://www.google.co.nz/url?sa=i&sou...05503013639963
More good news from Cellmid. Patent granted in Uk for use of midkine in hair growth restoration.
Advangen in the market in Japan, China and Australia, quarterly update in a couple of weeks, Quest to get its midkine marker lung cancer test out by Oct hopefully, Full year out at end of August, possible royalties from PEB and Quest.
Interesting times ahead and at .028 looks good for .029 at least
Finally broken through the .030 barrier, maybe the blocking seller has finished, either that or there is another load coming.
But thats neither hair nor there.
Revenue 2.8m, Profit/Loss -1.4m, Market Cap 20m. SP .03c Ballieu 07c - 26?c Hmmmmm, seems a bit undercooked by comparison especially with whats in the pipeline.:confused:
Big jump today on good volume ( 13 m so far) looked like the brakes had come off for a while.:)
might explain a bit: http://www.proactiveinvestors.com.au...267-57274.html
Yes, articles like this assist in giving a small co a higher profile. I often notice that news (good or bad) can take a few days to trickle through to the sp, particularly with small caps.
Fair sort of a jump in volume , nearly 20 million, think the instos might have woken up that this appears undervalued.
Sellers are a bit scarce and good volume building on the buy side but whether they will still be there at open is another matter.
Worth keeping an eye on CDY, not even back up to last CR point and revenues are building meanwhile.
DYOR